333 related articles for article (PubMed ID: 22789073)
1. The impact of extended-cycle vaginal ring contraception on migraine aura: a retrospective case series.
Calhoun A; Ford S; Pruitt A
Headache; 2012 Sep; 52(8):1246-53. PubMed ID: 22789073
[TBL] [Abstract][Full Text] [Related]
2. Extended regimens of the combined contraceptive vaginal ring containing etonogestrel and ethinyl estradiol: effects on lipid metabolism.
Barreiros FA; Guazzelli CA; Barbosa R; Torloni MR; Barbieri M; Araujo FF
Contraception; 2011 Aug; 84(2):155-9. PubMed ID: 21757057
[TBL] [Abstract][Full Text] [Related]
3. Combined hormonal contraceptives: is it time to reassess their role in migraine?
Calhoun A
Headache; 2012 Apr; 52(4):648-60. PubMed ID: 22221001
[TBL] [Abstract][Full Text] [Related]
4. Extended regimens of the contraceptive vaginal ring versus hormonal oral contraceptives: effects on lipid metabolism.
Guazzelli CA; Barreiros FA; Barbosa R; Torloni MR; Barbieri M
Contraception; 2012 Apr; 85(4):389-93. PubMed ID: 22067754
[TBL] [Abstract][Full Text] [Related]
5. [Combined hormonal contraception in cycles artificially extended].
Bustillos-Alamilla E; Zepeda-Zaragoza J; Hernández-Ruiz MA; Briones-Landa CH
Ginecol Obstet Mex; 2010 Jan; 78(1):37-45. PubMed ID: 20931801
[TBL] [Abstract][Full Text] [Related]
6. Ethinylestradiol + etonogestrel contraceptive vaginal ring: new drug. Possibly useful in some situations.
Prescrire Int; 2006 Apr; 15(82):50-3. PubMed ID: 16604729
[TBL] [Abstract][Full Text] [Related]
7. Extended regimens of the vaginal contraceptive ring: cycle control.
Guazzelli CA; Barreiros FA; Barbosa R; de Araújo FF; Moron AF
Contraception; 2009 Nov; 80(5):430-5. PubMed ID: 19835716
[TBL] [Abstract][Full Text] [Related]
8. Vaginal ring contraception.
Kerns J; Darney P
Contraception; 2011 Feb; 83(2):107-15. PubMed ID: 21237335
[TBL] [Abstract][Full Text] [Related]
9. The contraceptive vaginal ring.
Edwardson J; Jamshidi R
Semin Reprod Med; 2010 Mar; 28(2):133-9. PubMed ID: 20352563
[TBL] [Abstract][Full Text] [Related]
10. Clinical experience with the combined contraceptive vaginal ring in Switzerland, including a subgroup analysis of previous hormonal contraceptive use.
Merki-Feld GS; Hund M
Eur J Contracept Reprod Health Care; 2010 Dec; 15(6):413-22. PubMed ID: 21028953
[TBL] [Abstract][Full Text] [Related]
11. Effect of a contraceptive pill containing estradiol valerate and dienogest (E2V/DNG) in women with menstrually-related migraine (MRM).
Nappi RE; Terreno E; Sances G; Martini E; Tonani S; Santamaria V; Tassorelli C; Spinillo A
Contraception; 2013 Sep; 88(3):369-75. PubMed ID: 23453784
[TBL] [Abstract][Full Text] [Related]
12. Phase II dose-finding study on ovulation inhibition and cycle control associated with the use of contraceptive vaginal rings containing 17β-estradiol and the progestagens etonogestrel or nomegestrol acetate compared to NuvaRing.
Duijkers I; Klipping C; Heger-Mahn D; Fayad GN; Frenkl TL; Cruz SM; Korver T
Eur J Contracept Reprod Health Care; 2018 Aug; 23(4):245-254. PubMed ID: 30203681
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of combined hormonal vaginal ring in comparison to combined hormonal pills in heavy menstrual bleeding.
Dahiya P; Dalal M; Yadav A; Dahiya K; Jain S; Silan V
Eur J Obstet Gynecol Reprod Biol; 2016 Aug; 203():147-51. PubMed ID: 27285306
[TBL] [Abstract][Full Text] [Related]
14. Progestin-only contraception compared with extended combined oral contraceptive in women with migraine without aura: a retrospective pilot study.
Morotti M; Remorgida V; Venturini PL; Ferrero S
Eur J Obstet Gynecol Reprod Biol; 2014 Dec; 183():178-82. PubMed ID: 25461375
[TBL] [Abstract][Full Text] [Related]
15. The combined contraceptive vaginal ring, NuvaRing, and tampon co-usage.
Verhoeven CH; Dieben TO
Contraception; 2004 Mar; 69(3):197-9. PubMed ID: 14969666
[TBL] [Abstract][Full Text] [Related]
16. Clinical performance and menstrual bleeding patterns with three dosage combinations of a Nestorone progestogen/ethinyl estradiol contraceptive vaginal ring used on a bleeding-signaled regimen.
Weisberg E; Brache V; Alvarez F; Massai R; Mishell DR; Apter D; Gale J; Sivin I; Tsong YY; Fraser IS
Contraception; 2005 Jul; 72(1):46-52. PubMed ID: 15964292
[TBL] [Abstract][Full Text] [Related]
17. Effect of desogestrel 75 µg on headache frequency and intensity in women with migraine: a prospective controlled trial.
Merki-Feld GS; Imthurn B; Gantenbein AR; Sandor P
Eur J Contracept Reprod Health Care; 2019 Jun; 24(3):175-181. PubMed ID: 31094588
[No Abstract] [Full Text] [Related]
18. The combined contraceptive vaginal device (NuvaRing): a comprehensive review.
Sarkar NN
Eur J Contracept Reprod Health Care; 2005 Jun; 10(2):73-8. PubMed ID: 16147810
[TBL] [Abstract][Full Text] [Related]
19. Hormonal Contraceptives and Migraine With Aura-Is There Still a Risk?
Calhoun AH
Headache; 2017 Feb; 57(2):184-193. PubMed ID: 27774589
[TBL] [Abstract][Full Text] [Related]
20. Comparison of combined hormonal vaginal ring with ultralow-dose combined oral contraceptive pills in the management of heavy menstrual bleeding: A pilot study.
Agarwal N; Gupta M; Kriplani A; Bhatla N; Singh N
J Obstet Gynaecol; 2016; 36(1):71-5. PubMed ID: 26204126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
